Top stories

Congress has asked the government to approve the use of ‘Kovacin’ corona vaccine.

Senior Congress leader Anand Sharma expressed concern over the limited use of the Covid-19 vaccine by Bharat Biotech by India’s drug regulator. It also asked the government to explain why mandatory protocols and data validity were not followed. Sharma, head of the Parliamentary Committee on Home Affairs, said it was important to be extremely careful about the use of vaccines, as no country had compromised on the validation of three tests and data.

He said the third phase trials had not been completed as per the presentation made before the expert committee. Therefore, safety and impact statistics have not been reviewed, which is a mandatory requirement. He said the Ministry of Health should give various reasons for complying with the mandatory protocols and requirements in this case, as it includes health and safety workers working in front, unlike the Covid-19, who are under a limited category. Will be vaccinated.

Lack of clarity in DCGI’s statement

Anand Sharma said there was a lack of clarity in the DCGI statement. To avoid any confusion about the proven effectiveness of this vaccine, which was officially signed by the UK MHRA after an agreement was reached between the governments of the two countries, the government should present global efficacy test and final test data. Shared. He said the news of the arrival of vaccines and the introduction of vaccines was truly reassuring in an epidemic-hit country. It is also an honor for the world’s scientists, researchers and institutes, which have established India as the world’s largest vaccine manufacturer. Sharma said there were some concerns from the report recommending emergency approval of limited use in the case of any vaccine that is still in the third phase of investigation. This has actually raised concerns, as there are a variety of issues related to health care.

Why internationally adopted protocols are being revised: Jayaram Ramesh

Jairam Ramesh, another senior Congress leader, also expressed concern. He asked Union Health Minister Harsh Vardhan to explain why internationally accepted protocols were being amended in the third phase of the trial. He said on Twitter that India Biotech is a first-rate initiative, but it is surprising that internationally accepted protocols related to third-stage testing are being revised for Kovisin. Health Minister Harsh Vardhan should be clear.

Dr. Harshvardhan should make it clear: Tharoor

Senior Congress leader and Thiruvananthapuram MP Shashi Tharoor criticized the approval of cocaine, saying it was premature and dangerous. Tharoor tweeted, ‘Kovacin has not yet been tested for third stage. Time is given before approval and it can be dangerous. Dr. Harshvardhan should clarify this. This should be avoided until the full test.

Approved only after adequate testing of emergency use

The first issue was discussed extensively by the Parliamentary Standing Committee on Home Affairs. The committee recommended to the government that any vaccine for Kovid-19 should be approved after proper screening and adequate testing for emergency testing. In its report submitted to Rajya Sabha Chairman and Vice President M Venkaiah Naidu on December 21, the Parliamentary Standing Committee noted that the CDSC had not approved any emergency use in the past. It is therefore suggested that all necessary and mandatory requirements should be met and all steps of the test should be completed.


Show More

Related Articles

Leave a Reply

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker